Stay updated with breaking news from Commodore Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Commodore Capital LP acquired a new stake in Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 2,824,029 shares of the company’s stock, valued at approximately $21,914,000. Vera Therapeutics comprises about 3.3% of Commodore Capital LP’s investment portfolio, […]
Commodore Capital LP raised its position in Allakos Inc. (NASDAQ:ALLK – Free Report) by 15.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 1,900,000 shares of the company’s stock after acquiring an additional 256,500 shares during the period. Allakos makes up 1.3% of Commodore Capital LP’s investment […]
Commodore Capital LP acquired a new position in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 5,000,000 shares of the biotechnology company’s stock, valued at approximately $3,587,000. Adverum Biotechnologies accounts for 0.5% […]
Commodore Capital LP reduced its stake in shares of Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Free Report) by 19.7% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 400,000 shares of the company’s stock after selling 98,315 shares during the period. Commodore Capital LP owned approximately 0.98% of […]
Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) rose 7.9% during mid-day trading on Monday . The stock traded as high as $15.02 and last traded at $14.95. Approximately 78,930 shares traded hands during trading, a decline of 84% from the average daily volume of 483,739 shares. The stock had previously closed at $13.86. Analysts […]